These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32612357)

  • 1. Early Predictors of Mortality in Patients with COPD, in Relation to Respiratory and Non-Respiratory Causes of Death - A National Register Study.
    Henoch I; Ekberg-Jansson A; Löfdahl CG; Strang P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1495-1505. PubMed ID: 32612357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
    Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining prognosis in acute exacerbation of COPD.
    Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
    Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD
    J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
    Celli BR; Cote CG; Marin JM; Casanova C; Montes de Oca M; Mendez RA; Pinto Plata V; Cabral HJ
    N Engl J Med; 2004 Mar; 350(10):1005-12. PubMed ID: 14999112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Poor Short-Term Prognosis and Unmet Needs in Advanced Chronic Obstructive Pulmonary Disease: Use of the Two-Minute Walking Distance Extracted from a Six-Minute Walk Test.
    Neo HY; Xu HY; Wu HY; Hum A
    J Palliat Med; 2017 Aug; 20(8):821-828. PubMed ID: 28353374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise Ventilatory Inefficiency Adds to Lung Function in Predicting Mortality in COPD.
    Neder JA; Alharbi A; Berton DC; Alencar MC; Arbex FF; Hirai DM; Webb KA; O'Donnell DE
    COPD; 2016 Aug; 13(4):416-24. PubMed ID: 27077955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
    Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact Of Peak Oxygen Pulse On Patients With Chronic Obstructive Pulmonary Disease.
    Wu CW; Hsieh PC; Yang MC; Tzeng IS; Wu YK; Lan CC
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2543-2551. PubMed ID: 31819392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations.
    Ahn YH; Lee KS; Park JH; Jung JH; Lee M; Jung YJ; Chung WY; Sheen S; Park KJ; Kim DJ; Kang DR; Lee JD; Yoon S; Jin XJ; Yang HM; Lim HS; Park JS; Shin JH; Tahk SJ
    Respiration; 2015; 90(3):199-205. PubMed ID: 26278777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study.
    Zhang J; Rutten FH; Cramer MJ; Lammers JW; Zuithoff NP; Hoes AW
    Fam Pract; 2011 Oct; 28(5):474-81. PubMed ID: 21602286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease mortality, a competing risk analysis.
    Abukhalaf J; Davidson R; Villalobos N; Meek P; Petersen H; Sood A; Tesfaigzi Y; Vazquez Guillamet R
    Clin Respir J; 2018 Nov; 12(11):2598-2605. PubMed ID: 30257066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort.
    Odeyemi YE; Lewis O; Ngwa J; Dodd K; Gillum RF; Mehari A
    J Natl Med Assoc; 2019 Feb; 111(1):94-100. PubMed ID: 30064691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicity study of air pollution and mortality in Latin America (the ESCALA study).
    Romieu I; Gouveia N; Cifuentes LA; de Leon AP; Junger W; Vera J; Strappa V; Hurtado-Díaz M; Miranda-Soberanis V; Rojas-Bracho L; Carbajal-Arroyo L; Tzintzun-Cervantes G;
    Res Rep Health Eff Inst; 2012 Oct; (171):5-86. PubMed ID: 23311234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-arm and calf circumferences are stronger mortality predictors than body mass index for patients with chronic obstructive pulmonary disease.
    Ho SC; Wang JY; Kuo HP; Huang CD; Lee KY; Chuang HC; Feng PH; Chen TT; Hsu MF
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2075-80. PubMed ID: 27621613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits, for patients with late stage chronic obstructive pulmonary disease, of being cared for in specialized palliative care compared to hospital. A nationwide register study.
    Henoch I; Ekberg-Jansson A; Löfdahl CG; Strang P
    BMC Palliat Care; 2021 Aug; 20(1):130. PubMed ID: 34429078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of relevant variables and construction of a multidimensional index for predicting mortality in COPD patients.
    Xu L; Ye T; Li J; Hu Y; Xu W; Wang K; Ou C; Chen X
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1703-1711. PubMed ID: 31534324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.